Description:RecombinantmonoclonalantibodytoHIV-1protease.ManufacturedusingAbAb’sRecombinantPlatformwithvariableregions(i.e.specificity)fromthehybridomaF11.2.32.ThisisaFabfragmentwithahis-tag.
ThisreformattedmouseantibodywasmadeusingthevariabledomainsequencesoftheoriginalMouseIgG1format,forimprovedcompatibilitywithexistingreagents,assaysandtechniques.
SpeciesandIsotype:MouseFabfragment,His-Tagged,kappa
CloneNumber:F11.2.32
UniProtAccessionNumberofTargetProtein:PublishedApplication(s):neutralize;
ELISAPublishedSpeciesReactivity:HIV-1
Immunogen:F11.2.32waspreparedbygeneratingahybridomacelllineinwhichmyelomacellswerefusedwithsplenocytesderivedfromBALB/cmiceimmunizedwithHIV-1PRinthepresenceofFreund"sadjuvant.F11.2.32wasselectedforits
ABIlitytobindtoHIV-1PRbyELISA.
Specificity:F11.2.32FabbindstoHIV-1PRwithadissociationconstantof5nM(determinedbySPRatpH5.2)atanepitopeconsistingofMSLPGRWKPKM(aa36-46).HIV-1PRisahomodimericapartateproteasethatspecificallycleavestheviralGagandGag/Polpolyproteinprecursor.Acorrelationhasbeenobservedbetweentheactivityoftheproteaseandthedegreeofinfectivity,andsothisproteinisamajorantiviraltarget.
ApplicationNotes:TheIgGandFabvariantsofF11.2.32arebothabletostronglyinhibitthecatalyticactivityofHIV-1PR(IC50~35nM).InhibitionoccursbydistortingthenativestructureoftheHIV-1PRatthebaseoftheflapregion,whichplaysanimportantroleinregulatingaccesstotheactivesite.ThisantibodyisalsoabletodetectHIV-1PRbyELISA.
AntibodyFirstPublishedin:Lescaretal.Preliminarycrystallographicstudiesofananti-HIV-1proteaseantibodythatinhibitsenzymeactivityProteinSci. 1996May;5(5):966-8.PMID:8732768
Noteonpublication:DescribesthegenerationofthemAbF11.2.32anditscrystallizationincomplexwithpeptidefragmentsofHIV-1PR.
ProductForm
Purification:PurifiedbyImmobilizedMetalAffinityChromatography
Suppliedin:PBSwithpreservative(0.02%Proclin300)
StorageRecommendation:Storeat4°Cforupto3months.Forlongertermstoragealiquotintosmallvolumesandstoreat-20°C
Concentration:Seeviallabel.
Importantnote–Thisproductisforresearchuseonly.Itisnotintendedforuseintherapeuticordiagnosticproceduresforhumansoranimals.